The Administrative Core of the CIRNA will: (1) monitor and evaluate the progress of the CIRNA, by coordinating the activities of the executive committee and the advisory board;(2) enhance interdisciplinary education of CIRNA trainees and faculty, by coordinating seminars and workshops, and by distributing articles of relevance;(3) enhance interdisciplinary communication among CIRNA investigators and enhance synergy across CIRNA components by coordinating formal and informal meetings among project/core investigators, and maintaining an intranet site and list-serve; (4) facilitate the developmental research program (with the Career Development Core), which solicits and funds promising developmental proposals by trainees and junior faculty;(5) support the CIRNA as a national resource, by providing access to results of CIRNA research and educational information, and by implementing a comprehensive data sharing policy;and (6) provide administrative and budgetary oversight for the CIRNA. Drs. Lerman and Blendy will co-lead the CIRNA and its Administrative Core, with responsibilities based on complementary expertise in preclinical research (Blendy) and clinical research (Lerman).
The Administrative Core of the CIRNA will provide overall coordination of Center activities to promote cutting-edge science and education, and to facilitate the sharing of information with the scientific community.
|Ashare, Rebecca L; Lerman, Caryn; Cao, Wen et al. (2016) Nicotine withdrawal alters neural responses to psychosocial stress. Psychopharmacology (Berl) 233:2459-67|
|Forcelli, Patrick A; Turner, Jill R; Lee, Bridgin G et al. (2016) Anxiolytic- and antidepressant-like effects of the methadone metabolite 2-ethyl-5-methyl-3,3-diphenyl-1-pyrroline (EMDP). Neuropharmacology 101:46-56|
|Schnoll, Robert A; Hitsman, Brian; Blazekovic, Sonja et al. (2016) Longitudinal changes in smoking abstinence symptoms and alternative reinforcers predict long-term smoking cessation outcomes. Drug Alcohol Depend 165:245-52|
|Strasser, Andrew A; Souprountchouk, Valentina; Kaufmann, Amanda et al. (2016) Nicotine Replacement, Topography, and Smoking Phenotypes of E-cigarettes. Tob Regul Sci 2:352-362|
|Perkins, Kenneth A; Karelitz, Joshua L; Michael, Valerie C et al. (2016) Initial Evaluation of Fenofibrate for Efficacy in Aiding Smoking Abstinence. Nicotine Tob Res 18:74-8|
|Ashare, R L; Kimmey, B A; Rupprecht, L E et al. (2016) Repeated administration of an acetylcholinesterase inhibitor attenuates nicotine taking in rats and smoking behavior in human smokers. Transl Psychiatry 6:e713|
|Lee, Bridgin G; Anastasia, Agustin; Hempstead, Barbara L et al. (2015) Effects of the BDNF Val66Met Polymorphism on Anxiety-Like Behavior Following Nicotine Withdrawal in Mice. Nicotine Tob Res 17:1428-35|
|Falcone, M; Bansal-Travers, M; Sanborn, P M et al. (2015) Awareness of FDA-mandated cigarette packaging changes among smokers of 'light' cigarettes. Health Educ Res 30:81-6|
|Jhanjee, Sonali; Jain, Raka; Jain, Veena et al. (2015) Evaluating the Effects of Varenicline on Craving, Withdrawal, and Affect in a Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Varenicline for Smokeless Tobacco Dependence in India. J Psychoactive Drugs 47:325-30|
|Jain, Raka; Jhanjee, Sonali; Jain, Veena et al. (2015) Biochemical Validation of Self-Reported Smokeless Tobacco Abstinence among Smokeless Tobacco Users: Results from a Clinical Trial of Varenicline in India. J Psychoactive Drugs 47:331-5|
Showing the most recent 10 out of 104 publications